Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Acadia Healthcare | -2.880% | 5.303% | -1.418% | 8.594% | -1.418% | 37.624% | 141.907% |
Acadia Pharmaceuticals | 1.450% | 0.807% | -7.081% | -19.923% | -45.018% | -8.738% | -33.849% |
Acceleron Pharma Inc. | - | - | - | - | - | - | - |
Agios Pharmaceuticals Inc. | 3.380% | 7.746% | 15.909% | 50.000% | 48.544% | -34.165% | -32.703% |
Alnylam Pharmace. | 5.670% | 4.556% | -0.178% | -23.077% | -20.904% | 21.739% | 85.997% |
Amedisys Inc. | -0.590% | 1.198% | 0.000% | 17.361% | 0.000% | -63.889% | -19.996% |
Amicus Therapeutics Inc. | -3.550% | - | -10.377% | -9.524% | -28.571% | 15.152% | - |
Arena Pharmaceuticals Inc | - | - | - | - | - | - | - |
Arrowhead Pharmaceuticals Inc. | 2.590% | 10.343% | -7.404% | -29.568% | -20.064% | -62.806% | 43.669% |
Bio-Techne Corp. | 2.130% | 20.513% | 10.156% | -3.425% | -0.704% | - | - |
Bluebird Bio Inc. | 3.570% | -1.433% | -24.987% | -77.234% | -32.659% | -96.638% | - |
Blueprint Medicines Corp | 1.600% | 17.821% | 17.294% | 119.604% | 20.848% | 24.252% | - |
Bruker Corp. | 1.320% | -14.992% | -22.607% | -8.643% | -1.774% | - | - |
CONMED Corp. | 0.800% | 4.167% | -14.384% | -45.175% | -38.119% | -46.121% | -11.385% |
Davita Inc. | 4.600% | 7.108% | 5.742% | 66.082% | 40.436% | 36.757% | 162.055% |
Ensign Group Inc. | -1.800% | - | -1.786% | - | 6.796% | - | - |
Exelixis Inc. | -6.500% | -6.016% | -4.801% | 20.550% | -5.759% | 0.684% | 19.578% |
Fibrogen Inc. | -0.330% | - | -52.747% | -93.776% | 10.000% | -94.900% | - |
Genomic Health | -2.270% | - | - | - | - | - | - |
Global Blood Therapeutics Inc | - | - | - | - | - | - | - |
Halozyme Therapeutics Inc. | 3.000% | 1.697% | -1.065% | 27.619% | 9.749% | -10.590% | - |
Healthequity Inc. | - | 0.000% | -3.289% | 58.405% | 23.529% | 17.262% | - |
Hms Holdings Corp. | -1.270% | - | - | - | - | - | - |
Icu Medical Inc. | -0.550% | 4.000% | -6.667% | -46.154% | 1.676% | -46.784% | -55.772% |
Immunomedics Inc. | - | - | - | - | - | - | - |